Clinical Trial Research
New clinical trial research from University of California described
Published in Vaccine Weekly, December 31st, 2008
"New pre-clinical trials in AD mouse models may help to develop novel immunogen-adjuvant configurations with the potential to avoid the adverse responses that occurred during the clinical trials with AN-1792 vaccine formulation. Recently, we have pursued an alternative immunization strategy that replaces QS21 the Th1 type adjuvant used in the AN-1792 clinical trial with a molecular adjuvant, mannan that can promote a Th2-polarized immune response through interactions with mannose-binding and CD35/CD21 receptors of the innate immune system," scientists in the United States report.
"Previously we established that immunization of wild-type mice with mannan-A beta(28)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-12-31)
More Articles from Vaccine Weekly
- BioMed Central
Malaria Journal supplement evaluates steps toward elimination - University Hospital Heidelberg
Protection from the own immune system - Diarrhea
Patients with early Parkinsons disease experienced better symptom control and improvements in daily activities with StalevoŽ than carbidopa/levodopa, according to study - Hepatitic B Vaccines
Data on hepatitic b vaccines reported by K.N. Szomor and co-researchers - Immunization
Recent findings in immunization described by researchers from Hokkaido University, Medical Department - Immunization
Research on immunization reported by scientists at Khon Kaen University, Medical Department - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
